Januvia® Pancreatitis Lawsuit
PLEASE NOTE: Schmidt & Clark, LLP is no-longer accepting potential Januvia claims. If you feel that you have a case, we suggest that you locate another law firm experienced in mass tort litigation.
Januvia (sitagliptin) has recently been linked to an increased risk of serious life-threatening cases of pancreatitis, including acute, hemorrhagic and necrotizing pancreatitis.
What’s the problem?
On September 25, 2009 the U.S. Food & Drug Administration (FDA) notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin, were reported to the Agency between October 2006 and February 2009.
Side Effects of Januvia (sitagliptin)
Below is a list of the most serious side effects associated with Januvia and sitagliptin.
- Pancreatitis
- Acute Pancreatitis
- Hemorrhagic Pancreatitis
- Necrotizing Pancreatitis
- Death
Again, Schmidt & Clark, LLP is no-longer accepting potential Januvia claims. If you feel that you have a case, we suggest that you locate another law firm experienced in mass tort litigation.
To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
